Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
Danve AS, Kulkarni S. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus? American Journal Of Therapeutics 2017, 24: e347-e350. PMID: 26103543, DOI: 10.1097/mjt.0000000000000297.Peer-Reviewed Original ResearchMeSH KeywordsAntirheumatic AgentsArthritis, RheumatoidBlood GlucoseDiabetes MellitusHumansInflammationInsulin ResistanceTumor Necrosis Factor-alphaConceptsRheumatoid arthritisGlycemic controlTNF inhibitorsInsulin resistanceInsulin sensitivityTumor necrosis factor inhibitorsTumor necrosis factor alphaConcomitant rheumatoid arthritisInflammatory rheumatic diseasesNecrosis factor inhibitorsNecrosis factor alphaIncident diabetesDiabetes mellitusRheumatic diseasesFactor inhibitorsProinflammatory cytokinesFactor alphaPatientsMellitusArthritisInhibitorsDiabetesInflammationCytokinesDisease